Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Impact of non-pharmaceutical interventions on documented cases of COVID-19

View ORCID ProfileNicolas Banholzer, Eva van Weenen, Bernhard Kratzwald, Arne Seeliger, View ORCID ProfileDaniel Tschernutter, Pierluigi Bottrighi, Alberto Cenedese, Joan Puig Salles, View ORCID ProfileWerner Vach, View ORCID ProfileStefan Feuerriegel
doi: https://doi.org/10.1101/2020.04.16.20062141
Nicolas Banholzer
aDepartment of Management, Technology, and Economics, ETH Zurich, 8092 Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicolas Banholzer
Eva van Weenen
aDepartment of Management, Technology, and Economics, ETH Zurich, 8092 Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernhard Kratzwald
aDepartment of Management, Technology, and Economics, ETH Zurich, 8092 Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arne Seeliger
aDepartment of Management, Technology, and Economics, ETH Zurich, 8092 Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Tschernutter
aDepartment of Management, Technology, and Economics, ETH Zurich, 8092 Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel Tschernutter
Pierluigi Bottrighi
aDepartment of Management, Technology, and Economics, ETH Zurich, 8092 Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Cenedese
aDepartment of Management, Technology, and Economics, ETH Zurich, 8092 Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joan Puig Salles
aDepartment of Management, Technology, and Economics, ETH Zurich, 8092 Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Werner Vach
bBasel Academy, CH-4054 Basel, Switzerland
cDepartment of Environmental Sciences, University of Basel, CH-4055 Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Werner Vach
Stefan Feuerriegel
aDepartment of Management, Technology, and Economics, ETH Zurich, 8092 Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stefan Feuerriegel
  • For correspondence: sfeuerriegel@ethz.ch nbanholzer@ethz.ch
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The novel coronavirus (SARS-CoV-2) has rapidly evolved into a global epidemic. To control its spread, countries have implemented non-pharmaceutical interventions (NPIs), such as school or border closures, while others have even enforced complete lockdowns. Here we study the impact of NPIs in reducing documented cases of COVID-19. Documented case numbers are selected because they are essential for decision-makers in the area of health-policy when monitoring and evaluating current control mechanisms.

Methods We empirically estimate the relative reduction in the number of new cases attributed to each NPI. A cross-country analysis is performed using documented cases through April 15, 2020 from n = 20 countries (i.e., the United States, Canada, Australia, the EU-15 countries, Norway, and Switzerland).

Results As of April 15, venue closures were associated with a reduction in the number of new cases by 36 % (95% credible interval [CrI] 20–48 %), closely followed by gathering bans (34 %; 95% CrI 21–45 %), border closures (31 %; 95% CrI 19–42 %), and work bans on non-essential business activities (31 %; 95% CrI 16–44 %). Event bans lead to a slightly less pronounced reduction (23 %; 95% CrI 8–35 %). School closures (8 %; 95% CrI 0–23 %) and lockdowns (5 %; 95% CrI 0–14 %) appeared to be the least effective among the NPIs considered in this analysis.

Conclusions With this cross-country analysis, we provide early estimates regarding the impact of different NPIs for controlling the COVID-19 epidemic. These findings are relevant for evaluating current health-policies.

Competing Interest Statement

SF reports further grants from the Swiss National Science Foundation outside of the submitted work. JPS declares part-time employment at Luciole Medical outside of the submitted work. All other authors declare no competing interests.

Funding Statement

NB, EvW and SF acknowledge funding from the Swiss National Science Foundation (SNSF) as part of the Eccellenza grant 186932 on "Data-driven health management". The funding bodies had no control over design, conduct, data, analysis, review, reporting, or interpretation of the research conducted.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data availability

We collected data from publicly available data sources (Johns Hopkins Coronavirus Resource Center for epidemiological data; news reports and government resources for policy measures). All the public health information that we used is documented in the main text, the extended data and supplementary tables. A preprocessed data file is available with the codes.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted April 28, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Impact of non-pharmaceutical interventions on documented cases of COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Impact of non-pharmaceutical interventions on documented cases of COVID-19
Nicolas Banholzer, Eva van Weenen, Bernhard Kratzwald, Arne Seeliger, Daniel Tschernutter, Pierluigi Bottrighi, Alberto Cenedese, Joan Puig Salles, Werner Vach, Stefan Feuerriegel
medRxiv 2020.04.16.20062141; doi: https://doi.org/10.1101/2020.04.16.20062141
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Impact of non-pharmaceutical interventions on documented cases of COVID-19
Nicolas Banholzer, Eva van Weenen, Bernhard Kratzwald, Arne Seeliger, Daniel Tschernutter, Pierluigi Bottrighi, Alberto Cenedese, Joan Puig Salles, Werner Vach, Stefan Feuerriegel
medRxiv 2020.04.16.20062141; doi: https://doi.org/10.1101/2020.04.16.20062141

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Policy
  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (577)
  • Anesthesia (139)
  • Cardiovascular Medicine (1942)
  • Dentistry and Oral Medicine (252)
  • Dermatology (184)
  • Emergency Medicine (331)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (697)
  • Epidemiology (11090)
  • Forensic Medicine (8)
  • Gastroenterology (620)
  • Genetic and Genomic Medicine (3159)
  • Geriatric Medicine (307)
  • Health Economics (561)
  • Health Informatics (2040)
  • Health Policy (862)
  • Health Systems and Quality Improvement (782)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12702)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (334)
  • Neurology (2979)
  • Nursing (163)
  • Nutrition (462)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1548)
  • Ophthalmology (476)
  • Orthopedics (185)
  • Otolaryngology (265)
  • Pain Medicine (201)
  • Palliative Medicine (57)
  • Pathology (402)
  • Pediatrics (910)
  • Pharmacology and Therapeutics (381)
  • Primary Care Research (354)
  • Psychiatry and Clinical Psychology (2778)
  • Public and Global Health (5584)
  • Radiology and Imaging (1090)
  • Rehabilitation Medicine and Physical Therapy (631)
  • Respiratory Medicine (757)
  • Rheumatology (338)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (288)
  • Surgery (343)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (131)